Seeing Is Believing
Currently out of the existing stock ratings of Gregory Fraser, 50 are a BUY (90.91%), 5 are a HOLD (9.09%).
Analyst Gregory Fraser, carries an average stock price target met ratio of 49.04% that have a potential upside of 36.1% achieved within 194 days. Previously, Gregory Fraser worked at TRUIST.
Gregory Fraser’s has documented 110 price targets and ratings displayed on 19 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on JAZZ, Jazz Pharmaceuticals PLC at 06-Mar-2025.
Analyst best performing recommendations are on EOLS (EVOLUS).
The best stock recommendation documented was for EOLS (EVOLUS) at 2/24/2021. The price target of $12 was fulfilled within 2 days with a profit of $0.54 (4.71%) receiving and performance score of 23.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Oct-2021
$3
4 years 22 days ago
(23-Aug-2022)
0/2 (0%)
$2.55 (566.67%)
Hold Since 22-Aug-2022
$13
4 years 23 days ago
(22-Aug-2022)
0/1 (0%)
$8.7 (202.33%)
Buy Since 14-Oct-2021
$10
4 years 3 months 28 days ago
(17-May-2022)
0/1 (0%)
$4.78 (91.57%)
Buy Since 20-Sep-2021
$12
$11.98 (59900.00%)
4 years 11 months 25 days ago
(20-Sep-2021)
0/1 (0%)
$3.86 (47.42%)
Buy Since 20-Sep-2021
$20
$19.98 (99900.00%)
4 years 11 months 25 days ago
(20-Sep-2021)
0/1 (0%)
$11.86 (145.70%)